Aytu Biopharma, Inc
AYTU- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001385818
No open-market purchases or sales by Aytu Biopharma, Inc insiders were filed in the last 90 days; 38 institutions reported holding it in 13F filings for Q2 2026, worth $8.25M in total; no superinvestor holds it.
Q3 2023 vs. Q2 2023
How the institutions holding Aytu Biopharma, Inc changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 21 | 22 | +1 |
| Shares | 1.70M | 1.73M | +20.8K (+1.2%) |
| Value | $2.73M | $4.65M | +$1.93M (+70.7%) |
New holders (3)
Institutions that held Aytu Biopharma, Inc at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Northern Trust Corp | 14,568 | $39.3K | 0.00% |
| Vanguard Group Inc | 12,973 | $35.0K | 0.00% |
| CarsonAllaria Wealth Management, Ltd. | 5 | $14 | 0.00% |
Sold out (2)
Institutions that held Aytu Biopharma, Inc at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Prudential Financial Inc | 19,576 | $31.3K |
| Federated Hermes, Inc. | 177 | $283 |